BRPI0608077A2 - composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos - Google Patents

composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos

Info

Publication number
BRPI0608077A2
BRPI0608077A2 BRPI0608077-4A BRPI0608077A BRPI0608077A2 BR PI0608077 A2 BRPI0608077 A2 BR PI0608077A2 BR PI0608077 A BRPI0608077 A BR PI0608077A BR PI0608077 A2 BRPI0608077 A2 BR PI0608077A2
Authority
BR
Brazil
Prior art keywords
composition
compositions
alcoholic
dermatologically acceptable
manufacture
Prior art date
Application number
BRPI0608077-4A
Other languages
English (en)
Inventor
Monique Spann-Wade
Anthony J Ward
Original Assignee
Isw Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/361,384 external-priority patent/US20070053984A1/en
Application filed by Isw Group Inc filed Critical Isw Group Inc
Publication of BRPI0608077A2 publication Critical patent/BRPI0608077A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

COMPOSIçãO E COMPOSIçãO DE GEL ALCOóLICO DERMATOLOGICAMENTE ACEITáVEIS, MéTODO DE FABRICAçãO E USOS. A presente invanção refere-se a composições de gel alcoólico tópicas, as quais são úteis para distribuição de níveis terapêuticos de um NSAID a um alvo em e abaixo da pele. As composições compreendem um fármaco topicamente ativo, um solvente alcoólico, um espessante polimérico e opcionalmente um agen:e queratolítico. Em uma modalidade, excelente viscosidade para aplicação dérmica é obtida sem a necessidade de uma etapa para neutralização do pH da composição. Composições tópicas alcoólicas e isentas de álcool cor ipreendendo um pró-fármaco de NSAID também são descritas. As composições são particularmente úteis para o tratamento de pseudofolliculitis barbae,
BRPI0608077-4A 2005-03-03 2006-02-27 composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos BRPI0608077A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US65808405P 2005-03-03 2005-03-03
US68110205P 2005-05-13 2005-05-13
US69020105P 2005-06-14 2005-06-14
US11/361,384 US20070053984A1 (en) 2005-03-03 2006-02-24 Topical gels compositions
PCT/US2006/006780 WO2006096360A1 (en) 2005-03-03 2006-02-27 Topical gels compositions

Publications (1)

Publication Number Publication Date
BRPI0608077A2 true BRPI0608077A2 (pt) 2009-11-10

Family

ID=42334238

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0608077-4A BRPI0608077A2 (pt) 2005-03-03 2006-02-27 composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos

Country Status (10)

Country Link
EP (1) EP1858503B1 (pt)
JP (1) JP2008531693A (pt)
KR (1) KR20080008321A (pt)
AU (1) AU2006220964A1 (pt)
BR (1) BRPI0608077A2 (pt)
CA (1) CA2599968A1 (pt)
ES (1) ES2437201T3 (pt)
IL (1) IL185531A0 (pt)
MX (1) MX2007010681A (pt)
WO (1) WO2006096360A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7914814B2 (en) 1997-09-17 2011-03-29 Strategic Science & Technologies, Llc Topical delivery of arginine of cause beneficial effects
CA2563678A1 (en) 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US20080317684A1 (en) * 2006-09-06 2008-12-25 Isw Group, Inc. Topical Compositions
RU2463038C2 (ru) 2006-10-17 2012-10-10 Нуво Рисерч Инк. Диклофенаковый гель
ES2316312B1 (es) * 2008-06-20 2010-02-08 Ignacio Umbert Millet Composicion farmaceutica dermatologica para el tratamiento de patologias de inflamacion de la piel, tales como por ejemplo dermatitis, dermatitis atopica, vitiligo, alopecia areata, acne, psoriasis y prurito,y combinaciones de las mismas.
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
EP2445493A1 (en) * 2009-06-24 2012-05-02 Strategic Science & Technologies, LLC Topical composition containing naproxen
EP2445492B1 (en) * 2009-06-24 2016-09-28 Strategic Science & Technologies, LLC Topical composition containing ibuprofen
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
AU2015203547B2 (en) * 2009-06-24 2017-05-18 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法
KR101141938B1 (ko) 2010-01-22 2012-05-04 성균관대학교산학협력단 신규한 항생제 조성물 및 그람양성균의 치료 방법
EP2658551B1 (en) 2010-12-29 2020-07-01 Strategic Science & Technologies, LLC Treatment of erectile dysfunction and other indications
CN105878172A (zh) 2010-12-29 2016-08-24 战略科学与技术有限责任公司 治疗变态反应和其它适应症的系统和方法
AU2012250664B2 (en) 2011-05-03 2017-04-20 Aponia Laboratories, Inc. Transdermal compositions of ibuprofen and methods of use thereof
AU2015223035A1 (en) 2014-02-26 2016-09-22 Luma Therapeutics, Inc. Ultraviolet phototherapy apparatuses and methods
JP2019511343A (ja) 2016-02-09 2019-04-25 ルマ セラピューティクス，インク．Ｌｕｍａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 光線療法による乾癬処置の方法と組成物と装置

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS596287B2 (ja) * 1980-11-28 1984-02-10 日東電工株式会社 医薬製剤
WO1987002891A1 (en) 1985-11-07 1987-05-21 Pfizer Inc. Compounds and method for the topical treatment of inflammation and pain
US5093133A (en) 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
US5639738A (en) 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5976566A (en) 1997-08-29 1999-11-02 Macrochem Corporation Non-steroidal antiinflammtory drug formulations for topical application to the skin

Also Published As

Publication number Publication date
JP2008531693A (ja) 2008-08-14
KR20080008321A (ko) 2008-01-23
EP1858503B1 (en) 2013-09-04
ES2437201T3 (es) 2014-01-09
MX2007010681A (es) 2007-12-07
CA2599968A1 (en) 2006-09-14
WO2006096360A1 (en) 2006-09-14
AU2006220964A1 (en) 2006-09-14
EP1858503A1 (en) 2007-11-28
IL185531A0 (en) 2008-01-06

Similar Documents

Publication Publication Date Title
BRPI0608077A2 (pt) composição e composição de gel alcoólico dermatologicamente aceitáveis, método de fabricação e usos
MX2009000507A (es) Espuma farmaceutica de acidos grasos.
MX2009006088A (es) Nanoemulsion.
WO2007059979A3 (en) Allergy treatment by epicutaneous allergen administration
IN2012DN02817A (pt)
BR112015019657A8 (pt) composições tópicas, kit e método para aumentar a liberação de óxido nítrico a partir de um gel tópico anidro contendo uma macromolécula modificada de diazeniodiolato
WO2007002831A3 (en) Topical skin treating compostions
EA200702204A1 (ru) Лечение заболеваний соединительной ткани кожи
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
WO2008139122A3 (fr) Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations
BR112014019623A8 (pt) Composição aditiva de condicionamento para o fornecimento benefícios de longa duração e imediatos para substratos de queratina
MY158428A (en) Topical composition for the treatment of actinic keratosis
BRPI0510259A (pt) formulação cosmética ou dermatológica transparente
DK1982696T3 (da) Gel til behandling af sår
WO2005000241A8 (en) Compositons and methods for topical administration
WO2011059324A3 (en) Composition for topical application, uses thereof, applicator device and kit of parts
WO2009087354A3 (en) Skincare treatment
WO2015031971A8 (en) A composition comprising guaçatonga extract and aroeira extract/ use thereof and a method for preventing and/or treating signals caused by skin aging
MX2011012143A (es) Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas.
BR112015022590A2 (pt) nova composição farmacêutica para o tratamento de infecções fúngicas
WO2009150408A3 (en) Topical antimuscarinic formulations
MX2009012742A (es) Ingrediente activo novedoso en cicatrizacion y uso del mismo.
WO2014121048A3 (en) Topical compositions and methods for making and using same
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
WO2009129510A3 (en) Sulindac formulations in a biodegradable material

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2211 DE 21/05/2013.